Report on Healthcare Screening

Authors Avatar
"REPORT ON SCREENING"

Helen Lyford-smith

This report is a study on Screening. Living in the 21st century and as a result of this we have a large amount of knowledge established about various diseases, some of which can be cured, some of which scientists are still attempting to research and find solutions to, and some we can only endeavour to prevent.

The aspect of prevention is the key focus for this assignment. During this study I will go into the various aspects of Screening, looking specifically into each type in exploratory analysis and evaluation looking at the positive and negative sides of each type of screening and the problems associated with each of them.

Screening - an introduction

Screening is a systematic examination or assessment, done especially to detect an unwanted substance or attribute. Screening can be carried out through the National Health Service in general hospitals or by your GP, or can be carried out in private organisations such as BUPA. The UK Health Screening Programme covers a vast array of medical examination and assessment ranging from dentistry through to screening for cancer cells - all of which I will be going into further depth with during the course of this report. According to a popular health study by the UK National Screening Committee, (http://www.nsc.nhs.uk) Screening is a public health service in which members of a defined population, who do not necessarily perceive they are at risk of, or are already affected by a disease or its complications, are asked a question or offered a test, to identify those individuals who are more likely to be helped than harmed by further tests or treatment to reduce the risk of a disease or its complications.

Conditions and Regulations of Screening

There is no point in testing for conditions that do not respond differently when detected early. Yet in some cases it is vital for a person's survival of a disease to discover its presence as early on as possible, for example when screening for cancerous cells in a growth. It is vital that people attend routine tests and screenings, however people will not attend for routine tests if put to inconvenience and discomfort.

Such test should also be reliable and accurate, not giving figures of false positives or false negatives. These occur when the test result is judged to be different to the actual result; this has happened in the past for example with cervical smear screening results, and the modern UK media are quick to highlight such errors. This in turn causes negative views of screening as an entirety, putting people off having the screenings in the first place and causing raises levels of fatalities due to diseases failing to be detected early enough. Subsequently when considering a diagnostic test for screening populations it is important to consider the number of false negative and false positive results you will have to deal with. The quality of a diagnostic test is often expressed in terms of sensitivity and specificity. Sensitivity is the ability of the test to pick up what you are looking for and specificity is the ability of the test to reject what you are not looking for. One area of concern within the largely successful UK National Health Service breast screening programme is the relatively high proportion of women showing mammographic abnormalities who undergo further diagnostic tests that prove negative. Previous studies suggest that, in addition to increasing anxiety, such false-positive mammography is associated with increased risk of subsequent interval cancer. In a very recent study conducted by our Breast Cancer Research, (http://breast-cancer-research.com) concluded that last year in the UK there were around 11 unnecessary recalls for every cancer detected within the National Health Service breast screening programme, and the consequences of this are that large quantities of women were not attending recalls for later screenings, the likely cause of this being mistrust in the practice.

Nevertheless, screening provides valuable information that protects the health of different client groups and saves many lives. In a general overview, it is regarded as an integral part of our health care service.

Antenatal Screening Tests

Knowing a fetus is abnormal before birth allows parents to plan for any health needs of their baby in advance of it being born. It can also prepare them for the birth, enabling them to receive counselling before birth, reducing the shock and other reactions when the baby is born. As well as this, it gives the option of abortion of the fetus. Healthcare staff can also prepare for the delivery, and have suitable treatment ready for when the baby is born. The type of prenatal diagnosis done depends on the situation of the parents. In an older mother (for instance over 35), or a parent with an inheritable genetic condition, a more invasive technique may need to be done. This can detect chromosome abnormalities (such as Down's syndrome) which are more common as a woman's age increases, or a specific genetic problem that might run in the family. Genetic counseling is often offered to help parents decide what type of testing is right for their situation.

According to a popular study by Sahin Aksoy of the Department of Antentala Helath Screening, (www.biomedcentral.com/content) risk factors qualifying a woman for prenatal testing are the following, "pregnant women over the age of 35, women who have previously had premature babies or babies with a birth defect, especially heart or genetic problems, women who have high blood pressure, lupus, diabetes, asthma or epilepsy, or women whose partners have ethnic backgrounds prone to genetic disorders" During the course of a non high risk, normal pregnancy women are entitled to at least one scan - more would correlate with high risk pregnancies, such as those I have just described.

In some genetic conditions, for instance cystic fibrosis, an abnormality can only be detected if DNA is obtained from the baby. Usually an invasive method is needed to do this. If a genetic disease is detected, there is often no treatment that can help the fetus until it is born. It does give parents the option to consider abortion of the baby.

If abortion isn't an option for a particular couple (because of their own beliefs, such as catholicism), invasive prenatal diagnosis of such a condition is unhelpful as the test puts the child at risk, and knowing the result doesn't help the child. Genetic counseling can help families make informed decisions regarding results of prenatal diagnosis.

There is also the risks of ralse negatives and false positives to consider when evalutating the results of antenatal screenoing; Ultrasound, which is considered a screening test, of an unborn baby can sometimes miss subtle abnormalities. For example studies show that a detailed ultrasound, also called a level 2 ultrasound, can detect about 80% of spina bifida. Ultrasound results may also show "soft signs," such an Echogenic intracardiac focus or Choroid plexus cyst, which are usually normal, but can be associated with an increased risk for chromosome abnormalities. Other screening tests, such as the AFP triple test, can have false positives and false negatives. Even when the AFP triple test results are positive, usually the pregnancy is normal, but additional diagnostic tests may be offered. Both false positives and false negatives will have a large impact to a couple when they are told the result, or when the child is born. Diagnostic tests, such as amniocentesis, are considered to be very accurate for the defects they check for. No prenatal tests can detect all forms of virth defects and abnormalities.

There are definite ethical and practical issues involved in prenatal testing. The option to continue a pregnancy or to abort is the main choice after most prenatal testing. The risks must be weighed up - are the risks of prenatal diagnosis such as amniocentesis worth the potential benefit? In addition some fear that giving parents the option to abort 'unsatisfactory' babies may lead to being able to pick and choose what children parents would like to have. This could lead to choice in sex, physical characteristics, and personality in the children, creating a lot more abortions, and uneven population and ethnicity - it would also encourage the viewpoint of abortion being passable, with the birth of a child no longer holding any ethical or emotional value. Knowing about certain birth defects, such as spina bifida, before birth may give the option of foetal surgery during pregnancy, or to assure that the appropriate treatment and/or surgery is immediately available after birth - essentially giving the health care professionals and the parent's time to prepare. The choice also exposes the debate of whether mentally or physically disabled children are any less valuable in our society - health care professionals must ensure in this area of decision that they do not lead the parents into any one decision in their description of the child when informing the parents of the condition discovered. There are various antenatal screenings in use, which fall into two categories;

Non invasive methods (to the baby)

* Examination of the mother's uterus from outside the body. (i.e. Feeling the mother's stomach.)

* Ultrasound detection - Commonly used to check the baby's sex, to look for twins, and also to check for any abnormal development.

* AFP screening can check levels of alpha fetoprotein, ß-hCG, and estriol in the mother's serum.

* Detection of fetal blood cells in maternal blood. The mothers blood provides vital dissolved oxygen for the growing foetus anf this exchange takes place across the placenta. When the mother is aenemic then her foetus will not receive the desired amount of oxygen for its needs. The baby will be small for date and function may be imparied. A smaple of bloody taken from a vein in the mothers forearm will enable labarotory determination of the level of iron-containing haemoglobin in the red blood cells. When this is deemed inadaquate the pregnant mother can be supplied with the relevant medication. At the same time, this blood test can be analysed for certain chemicals, for exmaple high levels of alfafetoprotein, which would suggest the baby might have spina bifida. In addition, this blood test can be analysed to see whether the mother and baby have incompatable blood groups. This would require special precautions being taken so as not to mix the blood at birth, and in cases of complication, blood transfusions may be necessary. Essentially, if the mother has Rhesus negative (D-ve) blood and the foetus has Rhesus positive (D+ve) the first foetus may sensetise the mother by causing Rhesys antibodies to develop. This usually happens during the birth as the placenta is breaking away from the uterine wall. An injection of anti-D serum will take away the antibodies and prevent sensetisation. This is necessary because in a second or subsequent pregnancy with Rhesus positive baby, the mothers anitbodies will start to destroy the blood of the foetus, causing severe jaundice and in some cases, death.
Join now!


Invasive methods (to the baby)

* Chorionic villus sampling - Taken at ten weeks, CVS involves getting a sample of the chorionic villus and testing it. This can be done earlier than amniocentesis, but is a more risky procedure. Typical gentetic abnormalities investigated using CVS are Down's syndrome, heamophilia, thalassaemia, muscular dystrophy and sickle cell disorders. The test is carried out as an outpatient and takes around 30 minutes. The sample can be obtained from the foetal side of the edge of the placenta by a cannula attached to a syringe. Access is either trhough the vagina ...

This is a preview of the whole essay